Latest News

Sign up for our RSS Feed.
11 Apr 2014 NeurOp Receives Third Year of NIH Funding for Ischemia Research Read More
15 Apr 2013 NeurOp Receives Second Half of NIH Grant for Meeting Schizophrenia Research Mile ... Read More
Pipeline

Our most advanced compounds for major depression, neuropathic pain and ischemia demonstrate efficacy in animal models with no apparent toxicity at therapeutic doses. The chart below shows the progress towards our goal of placing a drug candidate in human clinical trials.

NR@B Program Click for more on Major Depression Click for more on Neruonal Protection Click for more on Neuropathic Pain